You are here

  • Home
  • Archive
  • Volume 15, Issue 2
  • The effectiveness and risks of Treating people with Idiopathic Pulmonary fibrosis with the Addition of Lansoprazole (TIPAL): study protocol for a randomised placebo-controlled multicentre clinical trial

Citation Tools

Article menu

Download PDFPDF

Respiratory medicine
Protocol
The effectiveness and risks of Treating people with Idiopathic Pulmonary fibrosis with the Addition of Lansoprazole (TIPAL): study protocol for a randomised placebo-controlled multicentre clinical trial

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Jones M, Cahn A, Chaudhuri N, et al
The effectiveness and risks of Treating people with Idiopathic Pulmonary fibrosis with the Addition of Lansoprazole (TIPAL): study protocol for a randomised placebo-controlled multicentre clinical trial
BMJ Open 2025;15:e088604. doi: 10.1136/bmjopen-2024-088604